© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 1, 74-75,
January 5, 2000
© 2000 Oxford University Press
BOOK REVIEW |
Inherited Susceptibility to Cancer: Clinical, Predictive and Ethical Perspectives
William D. Foulkes, Shirley V. Hodgson, eds. Cambridge (U.K.): Cambridge University Press, 1998. 456 pp., illus. $95.00. ISBN 0-521-56340-2
Correspondence to: Randall Burt, M.D., University of Utah School of Medicine, GI Division, 50 N. Medical Dr., Salt Lake City, UT 84132.
Cancer has historically been considered a disease of environmental exposure with the
exception of a few well-described, but rare, inherited syndromes. In the past 2 decades, it has
become increasingly apparent that inherited susceptibility plays a much larger role in human
cancer. Numerous cancer susceptibility genes have been identified, some of which relate to the
known inherited syndromes and some of which do not. Genes that confer susceptibility to colon,
breast, uterine, renal, and other malignancies are now known. Somatic inactivation of the genes
related to inherited cancer syndromes has been found in many cases to be important to